Uncategorized Archives - Page 96 of 112

ThursdayJun 14, 2018 10:53 am

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is “One to Watch”

Focused on California, the largest legal cannabis market in North America Operates an attractive royalty model that is beneficial for operators and the company Established partnerships with best-in-class operating entities Extensive network provides access to top-tier projects and operators Executive leadership team with 40+ years of combined experience in fund raising, capital management, corporate development, merchant and commercial banking FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages…

WednesdayJun 13, 2018 12:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on Delivery of Bioactive Substances via Oral Ingestion

Lexaria has its patented DehydraTECH™ nutrient infusion technology This technology has patent protection for cannabidiol and all other non-psychoactive cannabinoids DehydraTECH™ technology provides greater bio-absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a worldwide leader in enhancing the gastro-intestinal delivery of edible cannabinoid products. The company has its patented nutrient infusion technology called DehydraTECH™. This technology significantly improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other beneficial molecules. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has patents granted in the United States and Australia for applications of its…

WednesdayJun 13, 2018 11:28 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Extends Share Warrants Expiry amid Growing Alternative Medicine Popularity

PreveCeutical moves on recent stock split to boost share appeal Company’s organic therapeutics aim to relieve maladies for patients with diabetes, brain injuries and other conditions Alternative medicines market expected to generate nearly $200 billion in revenues by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) continues working to shore up its share appeal while seeking remedies for a variety of physical ailments through its nature-centric research to help patients with type 2 diabetes and obesity, mild traumatic brain injury, cancer and pervasive pain. PreveCeutical Medical completed a forward stock split last month on the basis of five…

TuesdayJun 12, 2018 12:39 pm

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces Launch into Beverage Industry

Strategic planning based off of 125 years of combined experience in the beverage industry Significant expected growth in the beverage and cannabis industry as the two join forces Multi-phase product to create a distribution platform for domestic and international markets Creating a sustainable and successful future that provides quality product worldwide The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), a company that produces farm-grown, high quality organic medical cannabis using organic craft growing principles, has announced a global strategic launch into the beverage industry. The company’s senior management has over 125 years of combined experience in the beverage…

TuesdayJun 12, 2018 12:09 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures California Extraction Deal as New Ontario Clinic Opens

Sunniva’s Sun-Oil Facility in California will provide Farmacy Phactory with distilled oil products Extraction deal is a significant milestone for the company, cements its position as a reliable manufacturer of clean extracted products New clinic opened in Windsor, Ontario, via wholly owned subsidiary Natural Health Services Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis provider, has struck an extraction deal with Farmacy Phactory, a family-run California cannabis farm (http://cnw.fm/uJ63k). Through wholly owned subsidiary CP Logistics, LLC, Sunniva’s Sun-Oil Facility will provide high quality, pure manufactured distilled oil products, including flavored oil formulations for vaporization cartridges. Sunniva will also…

MondayJun 11, 2018 1:02 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Set to Capitalize on Growth of Dietary Supplement, Drug Delivery Markets

Two separate market research reports predict 7.0 percent and 2.9 percent CAGR, respectively, in PreveCeutical’s areas of operation PreveCeutical developing Sol-Gel, an innovative medicine delivery platform Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is uniquely positioned to capitalize of the growth of two different markets in which it currently operates: dietary supplements and drug delivery systems. Two separate market research reports indicated recently that these sectors are expected to grow a projected 7.0 percent and 2.9 percent, respectively, over the next five years. In a report published in May, Technavio estimated that the global dietary…

MondayJun 11, 2018 12:21 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Reaffirms Expectations with Confirmation of Readiness from Health Canada

Sunniva confirms analyst expectations with COR from Health Canada Company and announcement featured in Seeking Alpha article Over one million square feet of cannabis cultivation facilities under construction Grow facilities in California and Canada target 60 million adults Biopharmaceutical company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) now seems set for a place in the sun. The North American provider of cannabis products and services announced on May 29, 2018, that its wholly owned subsidiary, Sunniva Medical Inc. (“SMI”), had received a Confirmation of Readiness (COR) notification from Health Canada. The good news has not gone unnoticed, with one analyst remarking,…

MondayJun 11, 2018 11:51 am

Xanthic Biopharma, Inc. (CSE: XTHC) Pursues Profitability in 2019 by Expanding Marketing of Cannabinoid-Infused Powders via Strategic Partners

xTHC produces cannabinoid-infused drink powders from a non-cannabis and non-hemp source using a patent-pending process Business model is to be a first-mover and expand into more U.S. states, with the focus now on the California market; goal is to reach broad-based retail channels, not only dispensaries Company is partnering with and is minority owner of Oregon-based Avitas CBD Water, LLC (now renamed Xanthic Beverages) Xanthic Biopharma, Inc. (CSE: XTHC), on its initial investor conference call, projected multi-million dollar revenue and profitability in 2019 as it grows. It is a manufacturer of CBD-infused drink powder from a non-cannabis and non-hemp, economically…

FridayJun 08, 2018 1:43 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) and the US Senate Celebrate Hemp History Week

U.S. Senate declares ‘Hemp History Week’ from June 4-10 Pending legislation in U.S. Congress to remove restrictions on hemp cultivation Hemp cultivation operations underway in the U.S. and Canada for Global Hemp Group Forty-eight years after the Controlled Substances Act (CSA) of 1970 criminalized its use, hemp may finally be escaping from its stigma as an illegal substance. An omen of that impending legitimacy appeared on Tuesday, June 5, 2018, when the U.S. Senate approved a resolution declaring June 4-10 ‘Hemp History Week’. The resolution made note of "the growing economic potential of industrial hemp" as well as its "historical relevance," and…

TuesdayJun 05, 2018 11:30 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Patent Portfolio, Announces Exercise of 450,000 Existing Warrants

LXRP, a drug delivery platform innovator, has been awarded two new patent grants in the U.S. and expects three more from Australia Company already has more than 40 patent awards or applications from 40 countries globally; it is preparing new patent application filings and predicts more patent awards this year LXRP received $63,000 from the exercise of 450,000 warrants previously granted to third parties Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is growing its patent portfolio with two more patent grants in the U.S., predicting three more from Australia, and it is currently preparing new patent application filings as it…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000

Category: Uncategorized